Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...

Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a leading provider of health science solutions, offering advanced technologies, expertise, and services that encompass complete workflows from ...

Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool. WALTHAM, Mass. & SAN DIEGO, January 13, 2025--Revvity, Inc. (NYSE ...

Revvity, Inc. (NYSE:RVTY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the fifteen research firms that are presently covering the stock, MarketBeat.com ...

Revvity, Inc. RVTY is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by its solid third-quarter 2024 performance and focus on artificial ...